Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations

Understanding the differences in biomarker prevalence that may exist among diverse populations is invaluable to accurately forecast biomarker-driven clinical trial enrollment metrics and to advance inclusive research and health equity. This study evaluated the frequency and types of PIK3CA mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jessica W., Murugesan, Karthikeyan, Newberg, Justin Y., Sokol, Ethan S., Savage, Heidi M., Stout, Thomas J., Maund, Sophia L., Hutchinson, Katherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812634/
https://www.ncbi.nlm.nih.gov/pubmed/36446041
http://dx.doi.org/10.1200/PO.22.00341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812634/
https://www.ncbi.nlm.nih.gov/pubmed/36446041
http://dx.doi.org/10.1200/PO.22.00341

Ejemplares similares